Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

Recent transfusion of immunoglobulin-containing products. The presence of antibodies without viral antigen or DNA. The presence of IgG anti-HBcAb but lack of IgM anti-HBcAb antibody (in our case ...

A single dose of hepatitis A vaccine is sufficient to convey rapid immunity, with nearly all subjects developing hepatitis A antibodies ... of hepatitis A and B antigen, whereas those receiving ...

Abstracts are available on the EASL Congress 2025 website at https://www.easlcongress.eu/. The posters are expected to be ...

bepirovirsen at a dose of 300 mg per week over 24 weeks resulted in sustained hepatitis B surface antigen (HBsAg) and HBV DNA loss to below the limits of detection in 9% to 10% of participants ...

10, 2024 — A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn't respond to prior ...

While antibiotics given in the first week of life reduce vaccine responses at 15 months, probiotics might counteract these ...

Apr. 23, 2025 — A team of biomedical researchers trained a machine learning algorithm to identify more than two dozen viable treatments for diseases caused by zoonotic pathogens that can jump ...

In my most recent column, I shared a few accounts from my personal and professional life that I consider “Stories Worth ...